Abstract
It was unclear whether sex hormone-binding globulin (SHBG) was a circulating biomarker of Alzheimer's disease (AD). We tested the cross-sectional relationships between plasma SHBG and cerebrospinal fluid (CSF) AD biomarkers in 707 non-demented adults. Next, the influences of plasma SHBG on dynamic changes of CSF Aβ42, hippocampus volume, brain metabolism, and cognition were explored in 448 non-demented adults from the Alzheimer's disease Neuroimaging Initiative (ADNI). Finally, the predictive and diagnostic values of plasma SHBG in AD were explored. A positive correlation was found between SHBG levels in plasma and CSF. Individuals with higher plasma SHBG levels had lower CSF Aβ42 (p < 0.005), after adjusting for age, gender, education, APOE4 allele, and cognitive scores. Though no significant difference of plasma SHBG was observed between mild AD dementia and healthy normal, plasma SHBG could contribute to accelerated rates of CSF Aβ42 decrease (p < 0.0005), decline in brain metabolism (p < 0.05), and hippocampus atrophy (p < 0.01), cognitive decline (p < 0.01), as well as higher risk of AD dementia (p < 0.05). These findings indicated plasma SHBG could be a prodromal biomarker to predict disease progression in AD.
References
Aug 1, 1989·Endocrine Reviews·C M Mendel
Jul 1, 1984·Neurology·G McKhannE M Stadlan
Jan 1, 1981·Endocrine Reviews·W M Pardridge
Sep 2, 1998·European Journal of Endocrinology·P LecomteM A Garrigue
Jan 28, 2004·Neurology·S D MoffatS M Resnick
Jan 30, 2004·Neurobiology of Aging·Elena K HoskinRichard Mayeux
Dec 8, 2004·Experimental Gerontology·E HogervorstA D Smith
Jul 5, 2006·Clinical Endocrinology·Carol A DerbyJohn B McKinlay
Sep 14, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·S M GapsturK Liu
Sep 19, 2006·Molecular and Cellular Biology·Helle Heibroch PetersenThomas E Willnow
Feb 28, 2008·Journal of Magnetic Resonance Imaging : JMRI·Clifford R JackMichael W Weiner
Oct 29, 2008·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·J D Caldwell, G F Jirikowski
Nov 22, 2008·Neurobiology of Aging·Majon MullerJosé A Luchsinger
Mar 20, 2009·Annals of Neurology·Leslie M ShawUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Aug 20, 2009·Current Alzheimer Research·Shannon L RisacherUNKNOWN Alzheimer's Disease Neuroimaging Initiative (ADNI)
Jan 1, 2010·Neurology·R C PetersenM W Weiner
May 11, 2010·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Michael W WeinerUNKNOWN Alzheimer's Disease Neuroimaging Initiative
May 11, 2010·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·John Q TrojanowskiUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Jan 1, 2010·Journal of Alzheimer's Disease : JAD·Leung-Wing ChuKaren S L Lam
May 31, 2012·Brain Imaging and Behavior·Laura E GibbonsUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jun 27, 2012·Hormones and Behavior·Meharvan Singh, Chang Su
Jul 12, 2012·Brain Imaging and Behavior·Paul K CraneUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Dec 19, 2015·Current Alzheimer Research·Jing XuGang Wang
Jun 17, 2016·Journal of Neuroendocrinology·M F RossettiR Cabrera
Jul 3, 2016·Neurology·Clifford R JackBruno Dubois
Oct 28, 2017·Brain and Behavior·Martine ElbejjaniLenore J Launer
Nov 11, 2017·Journal of Alzheimer's Disease : JAD·Loïc DayonJulius Popp
Mar 3, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Oskar HanssonUNKNOWN Alzheimer's Disease Neuroimaging Initiative